Agricultural Sciences and Technology
Why Cooley
-
Decades spent driving agtech innovation
Cooley’s lawyers have advanced the agricultural sciences landscape for decades, blending deep technical knowledge with commercial acumen. Our clients are industry pioneers and disruptors, from startups and global public companies to the investors backing game-changing technologies in the agricultural biotechnology, microbial engineering, microbiome, and food, animal and plant sciences industries.
-
Unrivaled legal platform for agtech visionaries
Our robust, full-service agtech platform supports innovators at every stage of the business cycle, providing counsel on market entry, regulatory compliance, investigations and litigation. Our team’s 40+ years at the US Food and Drug Administration’s Office of the General Counsel helps clients see around corners and get ahead of risks before they surface.
-
Connected to industry influencers
Our clients tap into one of the largest and most influential networks of venture capital firms, financial institutions and other strategic partners.
-
Holistic strategy integrating IP, corporate, regulatory and more
We build defensible, diligence-ready IP portfolios aligned with business objectives, integrating patent, corporate, litigation, partnering and regulatory strategy. Our “whole of government” approach is proven – hundreds of times over.
Cooley [lawyers] are very commercial-minded.
Recognition
- Chambers: Global Market Leader: Agribusiness (2025)
- Chambers USA: Band 1 for Startups and Emerging Companies (2025)
- Chambers USA: Intellectual Property – Nationwide (2025)
- BTI: Litigation Powerhouse (2026)
- The Legal 500 US: Tier 1 for Venture Capital and Startups (2025)
- LMG Life Sciences EMEA: Licensing and Collaboration Firm of the Year (2025)
- LMG Life Sciences: Patent Strategy and Management Firm of the Year – Honoree (2023)
- Managing IP: Ranked for Trademark Disputes and Prosecution (2024)
- PitchBook: #1 law firm for VC-backed exits – IPO and M&A (2025)
- World Trademark Review: Gold Tier for Trademark Law (2025)
Frequently asked questions
What is the focus of Cooley’s agricultural sciences and technology practice?
Cooley’s agricultural sciences and technology practice empowers agtech, foodtech and life sciences companies and their investors with end‑to‑end legal support. We guide innovators through market entry, financing, IP protection and regulatory strategy, and help them commercialize technologies spanning next‑generation plant breeding, biological inputs, microbial engineering, precision agriculture, and data‑driven crop and food system solutions.
What industries and technologies does Cooley’s agtech team work with?
Cooley advises clients advancing a spectrum of agricultural, biological and digital technologies – including genomic engineering tools (CRISPR, RNAi, base editing, TALENs), gene‑edited crops, predictive crop modeling, remote sensing, microbial compositions and treatments, agricultural biologicals, microbiome‑modulation platforms, recombinant microbes, nitrogen‑fixation technologies, alternative proteins, biofuels, synthetic biology, insect pheromone systems, and natural or organic crop protection solutions. Our experience spans row crops, specialty crops, horticulture and emerging food systems.
How does Cooley help clients navigate international regulatory and IP challenges?
Cooley helps agtech companies navigate complex regulatory and IP landscapes with practical, risk‑based guidance shaped by former FDA enforcement attorneys and lawyers with significant European Union regulatory insight. Our team supports clients developing advanced technologies – such as gene‑edited plants, microbial and biological products, bio‑based formulations, feed and food compositions, and new plant varieties – building diligence‑ready IP portfolios and guiding companies through US and international compliance requirements.
How does Cooley support agtech innovators and investors throughout the business life cycle?
Cooley supports agtech innovators and investors at every stage – from company formation and venture financing to IP portfolio development, strategic transactions, regulatory strategy and high-stakes litigation. Our cross‑disciplinary platform helps companies scale technologies, such as microbial engineering, high‑tech precision agriculture, next‑generation plant breeding, horticultural and floriculture innovation, alternative proteins and sustainable biological solutions, while connecting them to one of the most influential networks of venture capital firms and strategic partners in the agricultural sciences sector.
What makes Cooley unique in the agricultural sciences and technology sector?
Cooley combines scientific fluency with commercial and regulatory depth. With decades of FDA experience, a leading venture capital and emerging companies platform, and one of the largest life sciences IP teams in the US, we help clients safeguard transformative technologies – from crop genetics and microbial treatments to synthetic biology, biofuels and advanced biological inputs. Our integrated approach enables clients to anticipate risk, accelerate growth and compete confidently in rapidly evolving global markets.
Life sciences resources
From startup to scale, our industry resources equip life sciences leaders with curated insights on regulatory developments, financing trends, IP strategies and key legal considerations shaping the life sciences landscape
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.